In this article, we will discuss Durvalumab (Dosage Modifications-9). So, let’s get started.
- Exfoliative Dermatologic Conditions – Severity Suspected SJS, TEN, or DRESS – Withhold
- Severity Confirmed SJS, TEN, or DRESS – Permanently discontinue
In this article we will discuss Durvalumab (Dosage Modifications-9)